Metabolic Plasticity as a Determinant of Tumor Growth and Metastasis

Abstract

Cancer cells must adapt their metabolism to meet the energetic and biosynthetic demands that accompany rapid growth of the primary tumor and colonization of distinct metastatic sites. Different stages of the metastatic cascade can also present distinct metabolic challenges to disseminating cancer cells. However, little is known regarding how changes in cellular metabolism, both within the cancer cell and the metastatic microenvironment, alter the ability of tumor cells to colonize and grow in distinct secondary sites. This review examines the concept of metabolic heterogeneity within the primary tumor, and how cancer cells are metabolically coupled with other cancer cells that comprise the tumor and cells within the tumor stroma. We examine how metabolic strategies, which are engaged by cancer cells in the primary site, change during the metastatic process. Finally, we discuss the metabolic adaptations that occur as cancer cells colonize foreign metastatic microenvironments and how cancer cells influence the metabolism of stromal cells at sites of metastasis. Through a discussion of these topics, it is clear that plasticity in tumor metabolic programs, which allows cancer cells to adapt and grow in hostile microenvironments, is emerging as an important variable that may change clinical approaches to managing metastatic disease. Cancer Res; 76(18); 5201-8. Ó2016 AACR.

Unique Metabolic Adaptations Dictate Distal Organ-Specific Metastatic Colonization

“…Here, we propose that during their evolution, tumor cells acquire a metabolic signature adapted for survival at particular metastatic sites, which dictates where they are able to form distal colonies. This hypothesis is consistent with the growing body of evidence showing that the more metabolically flexible the primary tumor cells are, the more likely they are to survive the metastatic process and thrive in distant organs (Lehuede et al, 2016). …”

FR58P1a; a new uncoupler of OXPHOS that inhibits migration in triple-negative breast cancer cells via Sirt1/AMPK/β1-integrin pathway

“…In addition to serving as a source of energy and metabolites for proliferating cancer cells 11,36,41,42 , mitochondria have been described as essential during migration and metastasis in breast cancer cells 15,16 . During migration and metastasis, cancer cells must adhere to the extracellular matrix (ECM) 43 .…”

“…On the other hand, invasive metastatic breast cancer cells specifically favor mitochondrial respiration, to increase ATP levels, through a mechanism that involves overexpression of PGC-1α and increase mitochondrial biogenesis 14 . In fact, it has been shown that OXPHOS activity increases concomitantly with the metastatic potential in primary breast cancer 15,16 . Therefore, mitochondrial metabolism represents an attractive target for anti-metastatic approaches.…”

A new role for extracellular vesicles: how small vesicles can feed tumors' big appetite

“…Cancer cells must display a high metabolic plasticity to generate the energy and to meet the biosynthetic demand required to support their proliferation and dissemination in a poorly oxygenated and nutrient-deprived microenvironment (59,60 Moreover, in contrast to normal cells, cancer cells can simultaneously synthesize and utilize FAs through fatty acid oxidation (FAO) (67). The key role of FAO in cancer cell metabolism has recently emerged (68,69).…”